Morgan Stanley (NYSE:MS – Get Free Report) had its price objective upped by UBS Group from $130.00 to $140.00 in a research report issued to clients and investors on Tuesday,Benzinga reports. The firm presently has a “neutral” rating on the financial services provider’s stock. UBS Group’s price objective suggests a potential upside of 2.94% from the stock’s previous close.
A number of other equities analysts have also issued reports on the stock. Evercore ISI raised their price target on shares of Morgan Stanley from $140.00 to $150.00 and gave the stock an “outperform” rating in a research report on Friday, January 17th. Citigroup boosted their target price on shares of Morgan Stanley from $105.00 to $135.00 and gave the company a “neutral” rating in a research report on Monday, November 25th. JPMorgan Chase & Co. upped their price target on shares of Morgan Stanley from $104.00 to $108.00 and gave the company a “neutral” rating in a report on Monday, January 13th. The Goldman Sachs Group lifted their price objective on Morgan Stanley from $106.00 to $121.00 and gave the company a “neutral” rating in a research note on Thursday, October 17th. Finally, Jefferies Financial Group upped their target price on Morgan Stanley from $120.00 to $135.00 and gave the stock a “buy” rating in a research note on Thursday, October 17th. Eleven research analysts have rated the stock with a hold rating and six have issued a buy rating to the company. According to data from MarketBeat, the stock currently has an average rating of “Hold” and an average price target of $131.27.
Check Out Our Latest Analysis on Morgan Stanley
Morgan Stanley Trading Down 0.9 %
Morgan Stanley (NYSE:MS – Get Free Report) last posted its quarterly earnings results on Thursday, January 16th. The financial services provider reported $2.22 earnings per share for the quarter, beating the consensus estimate of $1.54 by $0.68. Morgan Stanley had a return on equity of 14.39% and a net margin of 12.48%. The business had revenue of $16.23 billion for the quarter, compared to the consensus estimate of $15.03 billion. During the same quarter in the previous year, the business earned $1.13 EPS. The company’s quarterly revenue was up 25.9% compared to the same quarter last year. On average, equities research analysts anticipate that Morgan Stanley will post 8.32 earnings per share for the current year.
Institutional Inflows and Outflows
Several hedge funds have recently modified their holdings of the stock. Peoples Bank KS purchased a new stake in Morgan Stanley during the 4th quarter worth approximately $25,000. Northwest Investment Counselors LLC purchased a new stake in shares of Morgan Stanley during the third quarter worth approximately $26,000. Rakuten Securities Inc. raised its stake in Morgan Stanley by 138.1% in the 3rd quarter. Rakuten Securities Inc. now owns 300 shares of the financial services provider’s stock valued at $31,000 after purchasing an additional 174 shares during the last quarter. Capital Performance Advisors LLP purchased a new position in Morgan Stanley in the 3rd quarter valued at $36,000. Finally, Planning Capital Management Corp boosted its stake in Morgan Stanley by 115.1% during the 3rd quarter. Planning Capital Management Corp now owns 357 shares of the financial services provider’s stock worth $37,000 after purchasing an additional 191 shares during the last quarter. Institutional investors and hedge funds own 84.19% of the company’s stock.
Morgan Stanley Company Profile
Morgan Stanley, a financial holding company, provides various financial products and services to corporations, governments, financial institutions, and individuals in the Americas, Europe, the Middle East, Africa, and Asia. It operates through Institutional Securities, Wealth Management, and Investment Management segments.
Further Reading
- Five stocks we like better than Morgan Stanley
- Breakout Stocks: What They Are and How to Identify Them
- Oracle Announces Game-Changing News for the AI Industry
- What Are Dividends? Buy the Best Dividend Stocks
- Netflix Adds 19 Million Subscribers, Growth Is Far From Over
- What Are Dividend Contenders? Investing in Dividend Contenders
- Tempus AI: A Game-Changer in AI-Powered Healthcare
Receive News & Ratings for Morgan Stanley Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Morgan Stanley and related companies with MarketBeat.com's FREE daily email newsletter.